Clinical Trials Browser

Phase 2 × Completed × Mid-low Rectal Cancer × Clear all

NCT06333769 2025-08-15

Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer

Phase 2 Completed

Gastrointestinal

Mid-low Rectal Cancer